Internal Med Medical News about Carcinoma, Hepatocellular

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Hedgehog Pathway Inhibitor Shrinks Medulloblastoma

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

MiR-122 affects the viability and apoptosis of hepatocellular carcinoma cells
Scandinavian Journal of Gastroenterology, 11/06/09

Wu X et al. – MiR–122 down–regulated the viability but up–regulated the apoptosis of hepatoma cell Huh–7. The absence of miR–122 expression in HepG2 cells was due to the loss of the miR–122 coding sequence in chromosome 18. These results imply that aberrant expression of miR–122 may contribute to hepatocarcinogenesis.

<< Previous
Mechanisms and Functional Implications of Intestinal Barrier...

Next >>
Attributional style and anxiety sensitivity as maintenance...